What is WINT's earnings growth forecast for 2025-2025?
(NASDAQ: WINT) Windtree Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.
Windtree Therapeutics's earnings in 2025 is -$20,749,000.
In 2025, WINT is forecast to generate -$7,908,384 in earnings, with the lowest earnings forecast at -$7,908,384 and the highest earnings forecast at -$7,908,384.
What is WINT's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: WINT) forecast ROE is N/A, which is considered weak.
What is WINT's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: WINT) Windtree Therapeutics's current Earnings Per Share (EPS) is -$933.98. In 2025, WINT's EPS is forecast to hit -$2.16 (min: -$2.16, max: -$2.16).
What is WINT's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: WINT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 10.9%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.